VistaGen Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
2028-03-31 |
2029-03-31 |
| Przychód (średnia) |
1.07 |
0.71 |
0.90 |
4.25 |
68.15 |
260.38 |
| Przychód Δ r/r |
0.00% |
-33.46% |
26.79% |
372.22% |
1503.62% |
282.04% |
| Przychód (min) |
0.85 |
0.28 |
0.90 |
4.25 |
67.87 |
260.38 |
| Przychód (max) |
1.21 |
1.38 |
0.90 |
4.25 |
68.44 |
260.38 |
| EBITDA (średnia) |
-0.64 |
-0.43 |
-0.54 |
-2.55 |
-40.89 |
-156.23 |
| EBIT (średnia) |
-0.64 |
-0.43 |
-0.54 |
-2.55 |
-40.89 |
-156.23 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-50.32 |
-53.19 |
-67.46 |
-58.20 |
-32.51 |
36.55 |
| Zysk netto % |
-4717.16% |
-7493.64% |
-7495.06% |
-1369.39% |
-47.70% |
14.04% |
| EPS (średnia) |
-1.60 |
-1.74 |
-1.66 |
-1.90 |
-1.01 |
1.19 |
| Liczba analityków (Przychody) |
3 |
3 |
3 |
3 |
3 |
2 |
| Liczba analityków (EPS) |
3 |
2 |
2 |
2 |
3 |
1 |
| symbol |
VTGN |
VTGN |
VTGN |
VTGN |
VTGN |
VTGN |